Welcome to the David H. Koch Institute for Integrative Cancer Research. By integrating the most advanced biological investigation with the best in engineering technology, we believe we can revolutionize the diagnosis, monitoring and treatment of cancer.
Our success will rely on engaging individuals from a broad range of expertise—both within this building and through our partners beyond these walls— in genuine collaboration. The Koch Institute includes over 40 laboratories and more than 650 researchers located at our headquarters and across the MIT campus. This group includes cancer biologists, genome scientists, chemists, engineers, and computer scientists, all dedicated to bringing the most advanced science and technology to bear in the fight against cancer.
Our goal is to make the David H. Koch Institute for Integrative Cancer Research the gold standard in interdisciplinary disease-focused research. Our organization is continually expanding a highly effective relationship network that involves other academic oncology centers, industrial partners and cancer-focused foundations.
As part of an institution of higher education, we are also deeply committed to training the next generation of cancer researchers. Fully three-quarters of the Koch Institute’s workforce are trainees, the next generation of leaders who will spread our new paradigm to leading laboratories and clinics around the world.
Together, we will be tireless in unraveling the complexities of cancer and bringing new discoveries to patients. This exciting new era could be the one that brings the goal of controlling cancer for good within our grasp.
Tyler Jacks, Ph.D.